Cargando…
L-4, a Well-Tolerated and Orally Active Inhibitor of Hedgehog Pathway, Exhibited Potent Anti-tumor Effects Against Medulloblastoma in vitro and in vivo
Inhibition of aberrant Hedgehog (Hh) pathway had been proved to be a promising therapeutic intervention in cancers like basal cell carcinoma (BCC), medulloblastoma (MB), and so on. Two drugs (Vismodegib, Sonidegib) were approved to treat BCC and more inhibitors are in clinical investigation. However...
Autores principales: | Zhu, Mingfei, Wang, Hong, Wang, Chenglin, Fang, Yanfen, Zhu, Tong, Zhao, Weili, Dong, Xiaochun, Zhang, Xiongwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393386/ https://www.ncbi.nlm.nih.gov/pubmed/30846937 http://dx.doi.org/10.3389/fphar.2019.00089 |
Ejemplares similares
-
Effects of metformin on Sonic hedgehog subgroup medulloblastoma progression: In vitro and in vivo studies
por: Fang, Huangyi, et al.
Publicado: (2022) -
Liposome-Imipramine Blue Inhibits Sonic Hedgehog Medulloblastoma In Vivo
por: MacDonald, Tobey J., et al.
Publicado: (2021) -
Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
por: Maximov, Victor, et al.
Publicado: (2019) -
Circular RNAs in Hedgehog Signaling Activation and Hedgehog-Mediated Medulloblastoma Tumors
por: Azatyan, Ani, et al.
Publicado: (2021) -
Targeting the Hedgehog Pathway in Pediatric Medulloblastoma
por: Huang, Sherri Y., et al.
Publicado: (2015)